Twist Bioscience Corp (TWST, Financial) is set to release its Q4 2024 earnings on Nov 18, 2024. The consensus estimate for Q4 2024 revenue is $82.20 million, and the earnings are expected to come in at -$0.70 per share. The full year 2024's revenue is expected to be $310.76 million and the earnings are expected to be -$3.52 per share. More detailed estimate data can be found on the Forecast page.
Twist Bioscience Corp (TWST, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Twist Bioscience Corp (TWST) for the full year 2024 have declined from $310.93 million to $310.76 million, and for 2025 from $373.19 million to $371.42 million. During the same period, earnings estimates for the full year 2024 have declined from -$3.43 per share to -$3.52 per share, while for 2025, the estimates have remained flat at -$2.43 per share.
Twist Bioscience Corp (TWST, Financial) Reported History
In the previous quarter of 2024-06-30, Twist Bioscience Corp's (TWST) actual revenue was $81.46 million, which beat analysts' revenue expectations of $77.40 million by 5.25%. Twist Bioscience Corp's (TWST) actual earnings were -$1.47 per share, which missed analysts' earnings expectations of -$0.75 per share by 95.48%. After releasing the results, Twist Bioscience Corp (TWST) was down by 19% in one day.
Twist Bioscience Corp (TWST, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 10 analysts, the average target price for Twist Bioscience Corp (TWST) is $53.09 with a high estimate of $62 and a low estimate of $46. The average target implies an upside of 43.91% from the current price of $36.89.
Based on GuruFocus estimates, the estimated GF Value for Twist Bioscience Corp (TWST, Financial) in one year is $57.47, suggesting an upside of 55.79% from the current price of $36.89.
Based on the consensus recommendation from 12 brokerage firms, Twist Bioscience Corp's (TWST, Financial) average brokerage recommendation is currently 2.1, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
